Medtronic plc (NYSE:MDT) went down by -1.01% from its latest closing price compared to the recent 1-year high of $122.15. The company’s stock price has collected 2.14% of gains in the last five trading sessions. Press Release reported 15 hours ago that The Foundry Announces Successful First-In-Human Procedure In Study Of Innovative Transcatheter Mitral Valve Repair Technology
Is It Worth Investing in Medtronic plc (NYSE :MDT) Right Now?
Medtronic plc (NYSE:MDT) scored a price-to-earnings ratio above its average ratio, recording 45.68 x from its present earnings ratio. Plus, the 36-month beta value for MDT is at 0.72. Opinions of the stock are interesting as 19 analysts out of 26 who provided ratings for Medtronic plc declared the stock was a “buy,” while 2 rated the stock as “overweight,” 5 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $129.96, which is $10.54 above the current price. MDT currently public float of 1.34B and currently shorts hold a 0.42% ratio of that float. Today, the average trading volume of MDT was 4.42M shares.
MDT’s Market Performance
MDT stocks went up by 2.14% for the week, with a monthly jump of 4.91% and a quarterly performance of 9.04%, while its annual performance rate touched -0.12%. The volatility ratio for the week stands at 1.79% while the volatility levels for the past 30 days are set at 1.63% for Medtronic plc. The simple moving average for the period of the last 20 days is 2.61% for MDT stocks with a simple moving average of 15.79% for the last 200 days.
Analysts’ Opinion of MDT
Many brokerage firms have already submitted their reports for MDT stocks, with Morgan Stanley repeating the rating for MDT by listing it as a “Overweight.” The predicted price for MDT in the upcoming period, according to Morgan Stanley is $140 based on the research report published on December 15th of the previous year 2020.
Goldman, on the other hand, stated in their research note that they expect to see MDT reach a price target of $119, previously predicting the price at $100. The rating they have provided for MDT stocks is “Neutral” according to the report published on December 15th, 2020.
Stifel gave a rating of “Buy” to MDT, setting the target price at $125 in the report published on October 08th of the previous year.
MDT Trading at 5.85% from the 50-Day Moving Average
After a stumble in the market that brought MDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.99% of loss for the given period.
Volatility was left at 1.63%, however, over the last 30 days, the volatility rate increased by 1.79%, as shares surge +5.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +15.51% upper at present.
During the last 5 trading sessions, MDT rose by +2.14%, which changed the moving average for the period of 200-days by +28.89% in comparison to the 20-day moving average, which settled at $115.78. In addition, Medtronic plc saw 1.16% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at MDT starting from Surface Carol A, who sale 15,000 shares at the price of $114.90 back on Dec 28. After this action, Surface Carol A now owns 34,150 shares of Medtronic plc, valued at $1,723,500 using the latest closing price.
Lerman Bradley E, the SVP General Counsel & Corp Sec of Medtronic plc, sale 2,605 shares at $115.56 during a trade that took place back on Dec 22, which means that Lerman Bradley E is holding 51,543 shares at $301,034 based on the most recent closing price.
Stock Fundamentals for MDT
Current profitability levels for the company are sitting at:
- +19.42 for the present operating margin
- +61.87 for the gross margin
The net margin for Medtronic plc stands at +16.56. The total capital return value is set at 7.38, while invested capital returns managed to touch 6.47. Equity return is now at value 7.00, with 3.80 for asset returns.
Based on Medtronic plc (MDT), the company’s capital structure generated 50.74 points at debt to equity in total, while total debt to capital is 33.66. Total debt to assets is 28.38, with long-term debt to equity ratio resting at 44.93. Finally, the long-term debt to capital ratio is 29.81.
When we switch over and look at the enterprise to sales, we see a ratio of 5.16, with the company’s debt to enterprise value settled at 0.17. The receivables turnover for the company is 5.32 and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.13.